H.B. Fuller rejects Ancora’s bid, to review asset sales

H.B. Fuller (FUL) rejected Ancora's second bid for its Building Adhesive Solutions unit, valuing it at $1.2B-$1.4B. The board deemed the offer insufficient, lacking details, and not capturing the unit's full value. The company will conduct a market check for select segments by year-end 2026 to maximize shareholder value and use proceeds for deleveraging.

H.B. Fuller's board rejected Ancora's revised $1.2B-$1.4B bid for its adhesives business, calling it undervalued. The company's shares are mentioned.

H.B. Fuller (FUL) rejected Ancora's $1.2–$1.4B bid for its Building Adhesive Solutions business, citing undervaluation. The company will conduct a market check of non-core segments to deleverage by year-end 2026, using proceeds from potential transactions.

FULLER H B CO (FUL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 H.B. Fuller Board Unanimously Rejects Second Unsolicited, Non-Binding Proposal for Building Adhesive Solutions Segment Announces market check for select market segments ST. PAUL, Minn.--(BUSINESS WIRE)-- H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL

H.B. Fuller (FUL) rejected a $1.2B–$1.4B bid for its Building Adhesive Solutions unit from Ancora and plans to explore market interest in other segments. The company views BAS as strategically important and will use any proceeds for debt reduction.

H.B. Fuller (FUL) proposed a cash acquisition of Advanced Medical Solutions (AMS) via a scheme of arrangement, with terms to be disclosed June 25, 2026. FUL insiders bought over $600K of stock in late September, near its 52-week low. The company yields ~2% and has a payout ratio under 30%.